Cigna Group
CINYSEAlpha Score of 46 reflects weak overall profile with moderate momentum, weak value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Cigna Group Performance Analysis Amidst Strong EPS Growth and Valuation Metrics
Apr 15, 2026Cigna Group (CI) currently trades at $340.04, positioning the stock at the upper bound of its 52-week range. The primary driver for recent market attention remains the significant 80.9% year-over-year EPS growth, which contrasts sharply with the company’s 11.2% revenue growth. Despite the robust earnings expansion, the stock maintains a P/E ratio of 31.88, reflecting investor expectations for future profitability. The firm’s net margin stands at 2.2%, highlighting the thin-margin nature of the healthcare sector even as earnings scale upward. From a technical perspective, the Alpha Score of 47.4 suggests a neutral market stance. The quality sub-score of 58.4 is the strongest component, indicating relative stability in operational execution compared to the momentum score of 42.2 and the value score of 40.5. Sentiment remains balanced at 50, suggesting that current price levels are well-supported by existing data but lack a clear directional catalyst. Investors should monitor whether the company can sustain its current EPS growth trajectory while managing margin pressures throughout the remainder of the fiscal quarter.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Mar 2, 26 | Neville Everett | See Remarks | SELL | 1.7K | $497K |
| Mar 2, 26 | Jones Nicole S | See Remarks | SELL | 2.3K | $667K |
| Nov 3, 25 | Cordani David | Chairman & CEO | BUY | 4.1K | $1000K |
| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| Citadel Ken Griffin | 886K | $243.80M | NEW |
| D.E. Shaw David Shaw | 309K | $85.09M | NEW |
| Point72 Steve Cohen | 154K | $42.28M | NEW |
| Renaissance Technologies Jim Simons (founder) | 47K | $12.86M | NEW |
| Marshall Wace | 908 | $249.9K | NEW |
| Politician | Date | Type | Amount |
|---|---|---|---|
| Jared Moskowitz D-FL | 2026-03-23 | sale | $1k – $15k |
| Gilbert Cisneros D-CA | 2026-03-13 | sale | $1k – $15k |
| Julie Johnson D-TX | 2025-09-23 | purchase | $1k – $15k |
| Julie Johnson D-TX | 2025-09-23 | sale | $1k – $15k |
| Jared Moskowitz D-FL | 2025-05-15 | purchase | $1k – $15k |
| Julia Letlow R-LA | 2025-04-22 | sale | $1k – $15k |
| Julie Johnson D-TX | 2025-03-19 | purchase | $1k – $15k |
| Jefferson Shreve R-IN | 2025-02-24 | purchase | $15k – $50k |
The Cigna Group is a global health services organization dedicated to providing a broad range of insurance products and related services. Its core offerings encompass medical, dental, behavioral health, pharmacy benefit management, vision care, and supplemental benefits. Through the Evernorth Health Services segment, it partners with health plans, employers, governmental organizations, and providers to address challenges in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery management. The Cigna Healthcare segment delivers comprehensive medical and coordinated solutions via U.S. Healthcare and International Health operations. Other Operations include ongoing and exited businesses, while Corporate handles interest expenses, litigation, pension plans, and overhead. The Cigna Group connects clients with providers, pharmacies, and wellness partners across the United States and select international markets in Asia, Europe, the Middle East, and Latin America, emphasizing integrated solutions for clinical needs and cost efficiency. Founded in 1792 and headquartered in Bloomfield, Connecticut, it serves individuals, employers, and organizations with data-driven care management and digital health tools.
Earnings calendar coming soon. Subscribe to get notified when CI reports next.
Get earnings alerts →